New precompetitive ways of working in the pharmaceutical industry are driving the development of new informatics systems to enable their execution and management. The European Lead Factory (ELF) is a precompetitive, 30-partner collaboration between academic groups, small–medium enterprises and pharmaceutical companies created to discover small molecule hits against novel biological targets. A unique HTS screening and triage workflow has been developed to balance the intellectual property and scientific requirements of all the partners. Here, we describe the ELF Honest Data Broker, a cloud-based informatics system providing the scientific triage tools, fine-grained permissions and management tools required to implement the workflow
Through the European Lead Factory model, industry-standard high-throughput screening and hit validat...
The first aim of the current research is to assess the value, hurdles and collaboration models of Re...
In the context of E-science and open access, visibility and impact of scientific results and data ha...
New precompetitive ways of working in the pharmaceutical industry are driving the development of new...
New precompetitive ways of working in the pharmaceutical industry are driving the development of new...
The European Lead Factory (ELF) provides preclinical researchers in Europe with an integrated hit id...
The European Lead Factory (ELF) is a pan-European public-private partnership established in 2013 and...
The European Lead Factory (ELF) is a public-private consortium aimed at delivering high quality hit ...
The European Lead Factory (ELF) is a unique collaborative public–private partnership aiming to deliv...
High-throughput screening (HTS) represents a major cornerstone of drug discovery. The availability o...
The identification of high-quality starting points for drug discovery is an enduring challenge in me...
High-throughput screening (HTS) represents a major cornerstone of drug discovery. The availability o...
The Joint European Compound Library (JECL) is a new high-throughput screening collection aimed at dr...
The Joint European Compound Library (JECL) is a new high-throughput screening collection aimed at dr...
Open data is considered the new oil. As oil can be used to produce fertilisers, pesticides, lubrican...
Through the European Lead Factory model, industry-standard high-throughput screening and hit validat...
The first aim of the current research is to assess the value, hurdles and collaboration models of Re...
In the context of E-science and open access, visibility and impact of scientific results and data ha...
New precompetitive ways of working in the pharmaceutical industry are driving the development of new...
New precompetitive ways of working in the pharmaceutical industry are driving the development of new...
The European Lead Factory (ELF) provides preclinical researchers in Europe with an integrated hit id...
The European Lead Factory (ELF) is a pan-European public-private partnership established in 2013 and...
The European Lead Factory (ELF) is a public-private consortium aimed at delivering high quality hit ...
The European Lead Factory (ELF) is a unique collaborative public–private partnership aiming to deliv...
High-throughput screening (HTS) represents a major cornerstone of drug discovery. The availability o...
The identification of high-quality starting points for drug discovery is an enduring challenge in me...
High-throughput screening (HTS) represents a major cornerstone of drug discovery. The availability o...
The Joint European Compound Library (JECL) is a new high-throughput screening collection aimed at dr...
The Joint European Compound Library (JECL) is a new high-throughput screening collection aimed at dr...
Open data is considered the new oil. As oil can be used to produce fertilisers, pesticides, lubrican...
Through the European Lead Factory model, industry-standard high-throughput screening and hit validat...
The first aim of the current research is to assess the value, hurdles and collaboration models of Re...
In the context of E-science and open access, visibility and impact of scientific results and data ha...